Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naga P Chalasani

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Gastroenterology & Hepatology|March 23, 2017
Perceptions of Hepatotoxicity in Medical TherapiesNaga P Chalasani
The American Journal of Gastroenterology|March 7, 2015
Response to LevyVictor Navarro, Naga P Chalasani
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 1, 2007
Metabolic syndrome following liver transplantation is associated with major vascular eventsSuthat Liangpunsakul, Naga P Chalasani
Clinical Liver Disease|May 2, 2019
Increasing impact of drug-induced liver injuryPaul H Hayashi, Naga P Chalasani
Clinics in Liver Disease|November 16, 2016
Drug Hepatotoxicity: Environmental FactorsJonathan G Stine, Naga P Chalasani
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 15, 2012
Liver injury in the elderly due to fluoroquinolones: should these drugs be avoided?Paul H Hayashi, Naga P Chalasani
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 8, 2026
New Lessons in DILI: Rising Hepatotoxicity of Oncologic Agents and Predicting Very Short-term Survival in DILI Liver FailureMarwan Ghabril, Raj Vuppalanchi, Naga P Chalasani
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 1, 2008
Insulin resistance, hepatitis C, and liver transplantationMazen Alsatie, Prashant Pandya, Naga P Chalasani
Gastroenterology|September 9, 2017
In Memoriam-Lawrence Lumeng, MD: Researcher, Clinician, Leader, Mentor, Family Man, and FriendNaga P Chalasani, David W Crabb, Douglas K Rex
Drug Safety|February 15, 2019
Drug-Induced Steatosis and Steatohepatitis: The Search for Novel Serum Biomarkers Among Potential Biomarkers for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic SteatohepatitisLauren Pavlik, Arie Regev, Paul A Ardayfio, et al.
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Gastroenterology & Hepatology|March 23, 2017
Perceptions of Hepatotoxicity in Medical TherapiesNaga P Chalasani
The American Journal of Gastroenterology|March 7, 2015
Response to LevyVictor Navarro, Naga P Chalasani
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 1, 2007
Metabolic syndrome following liver transplantation is associated with major vascular eventsSuthat Liangpunsakul, Naga P Chalasani
Clinical Liver Disease|May 2, 2019
Increasing impact of drug-induced liver injuryPaul H Hayashi, Naga P Chalasani
Clinics in Liver Disease|November 16, 2016
Drug Hepatotoxicity: Environmental FactorsJonathan G Stine, Naga P Chalasani
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 15, 2012
Liver injury in the elderly due to fluoroquinolones: should these drugs be avoided?Paul H Hayashi, Naga P Chalasani
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 8, 2026
New Lessons in DILI: Rising Hepatotoxicity of Oncologic Agents and Predicting Very Short-term Survival in DILI Liver FailureMarwan Ghabril, Raj Vuppalanchi, Naga P Chalasani
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 1, 2008
Insulin resistance, hepatitis C, and liver transplantationMazen Alsatie, Prashant Pandya, Naga P Chalasani
Gastroenterology|September 9, 2017
In Memoriam-Lawrence Lumeng, MD: Researcher, Clinician, Leader, Mentor, Family Man, and FriendNaga P Chalasani, David W Crabb, Douglas K Rex
Drug Safety|February 15, 2019
Drug-Induced Steatosis and Steatohepatitis: The Search for Novel Serum Biomarkers Among Potential Biomarkers for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic SteatohepatitisLauren Pavlik, Arie Regev, Paul A Ardayfio, et al.
Pageof 8